Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robin Deterding

Pediatric Pulmonology Aurora, CO Medical Doctor

NPI 1700961430 CMS profile 411718

13123 E 16Th Ave, Aurora, CO 80045

Open in the dashboard

General payments

$107,923

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$421,500

4 holdings reported · through program year 2025

Research they led as principal investigator

$1,000,425 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Robin Deterding of Aurora, CO is reported in the CMS Open Payments database as having received $107,923 across 63 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,000,425 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $421,500 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,653 7
2024 General $32,521 17
2023 General $25,932 9
2022 General $5,873 9
2021 General $10,257 6
2020 General $4,251 6
2019 General $16,435 9
2025 Ownership $69,000 1
2024 Ownership $34,500 1
2023 Ownership $217,500 1
2022 Ownership $100,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robin Deterding
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Robin Deterding were reported at $12,653. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Robin Deterding Pediatric Pulmonology median Middle half National median
2019 $16,435 $151 $59–$495 $163
2020 $4,251 $107 $34–$339 $114
2021 $10,257 $125 $40–$511 $132
2022 $5,873 $133 $49–$428 $149
2023 $25,932 $138 $44–$494 $160
2024 $32,521 $132 $46–$398 $164
2025 $12,653 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $65,971 46 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $29,931 12 payments
  3. EvoEndo, Inc $11,340 3 payments
  4. Roche Products Limited $560 1 payment
  5. Philips Electronics North America Corporation $120 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $76,403 25 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,743 21 payments
  3. Travel and Lodging $15,106 7 payments
  4. Food and Beverage $671 10 payments
Products named General payments · program years 2019–2025
  1. OFEV Respiratory $41,797 28 payments
  2. OFEV Respiratory $30,206 15 payments
  3. OFEV Oncology $16,315 8 payments
  4. Contactless Monitor $120 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record